SIS
IHE icon

Sound Income Strategies’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Sound Income Strategies’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-88
Closed -$7.72K – 1379
2026
Q1 		$7.72K Hold
88
– – ﹤0.01% 1638
2025
Q4 		$7.54K Buy
+88
New +$7.02K ﹤0.01% 1616

Other funds holding IHE

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
MCM
Monument Capital Management Alexandria, Virginia $497M AUM 52.58% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Sound Income Strategies's IHE Position: Q2 2026 in Review

Sound Income Strategies sold out of iShares US Pharmaceuticals ETF (IHE) in Q2 2026, closing a stake of 88 shares — an estimated $7.72K sold.

Sound Income Strategies first reported a position in IHE in Q4 2025 and held it in 2 quarters. The position peaked at $7.72K in Q1 2026. 175 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

  • Sound Income Strategies reported no remaining iShares US Pharmaceuticals ETF position as of Q2 2026 after selling out during the quarter.
  • Sound Income Strategies sold 88 iShares US Pharmaceuticals ETF shares in Q2 2026, an estimated $7.72K.
  • Sound Income Strategies first reported a position in iShares US Pharmaceuticals ETF in Q4 2025 and held it in 2 quarters.
  • Sound Income Strategies's iShares US Pharmaceuticals ETF position peaked at $7.72K in Q1 2026.
  • 175 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on Sound Income Strategies's 13F filing for Q2 2026, filed 20 Jul 2026.